Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis

BACKGROUND: Lactate dehydrogenase (LDH) as a hypoxia-regulator plays a vital role in alternative metabolic pathways of cancer cells. Numerous studies have assessed the prognostic value of elevated pretreatment LDH in malignant mesothelioma (MM). However, the results have been largely inconsistent. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Yi, Lin, Lanying, Wei, Shushan, Zhang, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207566/
https://www.ncbi.nlm.nih.gov/pubmed/28033270
http://dx.doi.org/10.1097/MD.0000000000005706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207566/
https://www.ncbi.nlm.nih.gov/pubmed/28033270
http://dx.doi.org/10.1097/MD.0000000000005706

Ejemplares similares